enGene Therapeutics ENGN Income Statement (2022-2026)

NASDAQ ENGN
$1.77 -0.08 (-4.32%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Shares Outstanding (Entity) (Quarter) 0.67M0.67M0.70M0.70M0.69M23.20M44.16M44.22M37.78M50.98M51.07M51.11M52.02M66.99M66.99M
Operating items
Research & Development (Quarter) 3.67M3.21M3.90M5.67M5.64M9.86M11.55M11.27M19.97M20.21M22.57M31.72M22.25M22.20M
Selling, General & Administrative (Quarter) 0.96M1.52M2.35M4.77M5.13M7.46M5.21M6.18M6.64M6.92M7.37M7.76M8.93M9.77M
Restructuring Costs (Quarter) 3.03M2.49M3.79M4.09M
Other Operating Expenses (Quarter) -55.14M-31.64M-2.49M-3.79M-4.09M
Operating Expenses (Quarter) 4.63M4.74M6.25M10.44M10.77M17.31M16.76M-37.69M-2.00M27.12M29.95M39.48M31.18M31.97M
Operating Income (Quarter) -4.63M-4.74M-6.25M-10.44M-10.77M-17.31M-16.76M-17.45M-26.61M-27.12M-29.95M-39.48M-31.18M-31.97M
EBIT (Quarter) -4.63M-4.74M-6.25M-10.44M-10.77M-17.31M-16.76M-17.45M-26.61M-27.12M-29.95M-39.48M-31.18M-31.97M
Non-operating items
Interest & Investment Income (Quarter) 0.17M0.15M0.39M0.41M1.02M2.98M3.38M3.02M2.73M2.49M2.23M1.98M2.74M2.66M
Other Non Operating Income (Quarter) -0.28M-0.44M0.40M-0.37M0.09M-0.05M-0.09M0.04M-0.20M-0.28M-0.12M-0.49M-0.18M
Non Operating Income (Quarter) -2.79M-0.55M1.53M-72.04M0.03M2.35M2.58M2.17M2.02M1.55M1.20M1.10M1.43M1.74M
Net income details
EBT (Quarter) -7.42M-5.28M-4.72M-82.48M-10.74M-14.96M-14.18M-15.28M-24.60M-25.57M-28.75M65.35M-29.75M-30.23M
Tax Provisions (Quarter) 0.02M-0.03M0.02M-0.03M0.02M0.02M0.24M0.24M-0.50M
Profit After Tax (Quarter) -7.42M-5.28M-5.99M-82.50M-10.71M-14.98M-14.15M-15.30M-24.62M-25.82M-29.23M-37.88M-29.75M-30.23M
Income from Continuing Operations (Quarter) -7.42M-5.28M-4.72M-82.50M-10.71M-14.98M-14.15M-15.30M-24.62M-25.82M-28.99M65.85M-29.75M-30.23M
Consolidated Net Income (Quarter) -7.42M-5.28M-4.72M-82.50M-10.71M-14.98M-14.15M-15.30M-24.62M-25.82M-28.99M65.85M-29.75M-30.23M
Income towards Parent Company (Quarter) -7.42M-5.28M-4.72M-82.50M-10.71M-14.98M-14.15M-15.30M-24.62M-25.82M-28.99M65.85M-29.75M-30.23M
Net Income towards Common Stockholders (Quarter) -7.42M-5.28M-4.72M-82.50M-10.71M-14.98M-14.15M-15.30M-24.62M-25.82M-28.99M-37.88M-29.75M-30.23M
Additional items
EPS (Basic) (Quarter) -11.39-7.61-6.73-119.11-0.46-0.38-0.32-0.40-0.48-0.51-0.57-0.74-0.44-0.43
EPS (Diluted) (Quarter) -11.39-7.61-6.73-119.11-0.46-0.38-0.32-0.40-0.48-0.51-0.57-0.74-0.44-0.43
Shares Outstanding (Quarter) 0.66M0.65M0.69M0.70M0.69M23.20M39.44M44.17M37.78M50.98M51.02M51.10M51.12M67.26M69.72M
Shares Outstanding (Diluted) (Quarter) 0.66M0.65M0.69M0.70M0.69M23.20M39.44M44.17M37.78M50.98M51.02M51.10M51.12M67.26M69.72M
EBITDA (Quarter) -4.63M-4.74M-6.25M-10.44M-10.77M-17.31M-16.76M-17.45M-26.61M-27.12M-29.95M-39.48M-31.18M-31.97M
Interest Expenses (Quarter) 0.20M1.18M1.18M1.44M-0.00M0.60M41.18M20.72M0.16M0.80M4.47M4.13M1.42M0.73M10.87M
Tax Rate (Quarter) -0.020.28-0.140.20-0.12-0.07-0.94-0.83-0.76